Cancer BiologyCancer LettersPeer-reviewed
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina…·Wěi Li
This study evaluates the biological activity of 60c, a next-generation colchicine-binding site inhibitor, showing improved potency and anti-metastatic effects in triple-negative breast cancer models.
5 citations